How do you pay?

How to pay the least

Ask for the cash price

Skyrizi

Skyrizi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Skyrizi’s cash price, and one or two other pharmacies too.
  2. Skyrizi’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

Compare every option

Question
Brand nameSkyrizi
Authorized genericrisankizumab-rzaa
Regular genericrisankizumab-rzaa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Skyrizi?
The original
–
–

Brand nameThe maker’s card

Skyrizi Complete Savings Card

Savings card from AbbVie

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

The card takes up to $14,000 a year off your co-pay.

Sign up on skyrizi.com 

Or call 1-866-759-7494.

In the maker’s words

“If you’re eligible for the Skyrizi Complete Savings Card, you may pay as little as $0 per dose…”

From the maker’s offer on skyrizi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Skyrizi itself, from the same company, sold without the brand name, and usually for less. For now Skyrizi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Skyrizi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SKYRIZI is an interleukin-23 antagonist indicated for the treatment of:

  • moderate-to-severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for systemic therapy or phototherapy.
  • active psoriatic arthritis in adults and pediatric patients 6 years of age and older.
  • moderately to severely active Crohn's disease in adults.
  • moderately to severely active ulcerative colitis in adults.

Source: the FDA label for Skyrizi (AbbVie Inc.), June 15, 2026. Full label on DailyMed 

Good to know